[Hematologic malignancies in pregnancy].
OBJECTIVE
To summarize available data concerning hematologic malignancies in pregnancy.


METHODS
Review article.


METHODS
Department of Obstetrics and Gynekology, Fakulty of Medicine, Masaryk University and University Hospital Brno.


METHODS
Compilation of published data from scientific literature.


CONCLUSIONS
Cancer complicating pregnancy is a rare coexistence. The incidence is approximately 1 in 1,000 pregnancies. The most frequent hematologic malignant tumor is Hodgkin's lymphoma, leukemia is less frequent and myeloproliferative diseases complicating pregnancy are sporadic coexistence. Symptoms of these deseases are often nonspecific and disguised in pregnancy, then the diagnosis can be late. It is imperative that a multidisciplinary team involving hematooncologist and obstetrician (pediatric specialist) care for patient with hematologic malignancies. Cleary, every patient have to know whole prognosis and all risk factors of treatment. Optimum timing of delivery is after 36th week of pregnancy (when chemotherapy is ended more than two weeks ago). We prefer vaginal delivery to caesarean section.
Doubek
R
R
Gynekologicko-porodnická klinika LF MU a FN, Brno. radandoubek@seznam.cz
Petrovová
D
D
Kalvodová
J
J
Doubek
M
M
D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000628:therapy; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000628:therapy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000628:therapy